View Post

Consensus Called for When Choosing Optimal Treatment for Breast Cancer–Related Lymphedema

In In The News by Barbara Jacoby

By: Maggie L. Shaw From: More than 20% of breast cancer survivors are severely affected by upper-limb breast cancer–related lymphedema (BCRL), which has debilitating adverse effects that include depression, chronic pain, functional impairment, recurrent skin infections, poor body image, and anxiety—all having an impact on overall long-term health-related quality of life (HRQOL). The 2 principal treatment modalities are complex …